Next-day residual effects of hypnotics in DSM-IV primary insomnia: A driving simulator study with simultaneous electroencephalogram monitoring

Psychopharmacology

Volumn 181, Issue 4, 2005, Pages 790-798

  Staner, Luc ^a   Ertlé, Stéphane ^a   Boeijinga, Peter ^a   Rinaudo, Gilbert ^a   Arnal, Marie Agnès ^a   Muzet, Alain ^b   Luthringer, Rémy ^a  

^a Centre Hospitalier de Rouffach   (France)

^b CNRS   (France)

Author keywords

Driving simulator; Hangover effects; Hypnotics; Insomnia

Indexed keywords

HYPNOTIC AGENT; LORMETAZEPAM; PLACEBO; ZOLPIDEM; ZOPICLONE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INSOMNIA; MALE; PRIORITY JOURNAL; SIMULATION; SLEEP; VELOCITY;

ADULT; AROUSAL; AUTOMOBILE DRIVING; CIRCADIAN RHYTHM; COMPUTER SIMULATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; PIPERAZINES; PYRIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 25844508838     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0082-8     Document Type: Article

References (47)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. APA, Washington, DC
2. Barbone F, McMahon AD, Davey PG, Morris AD, Ried IC, McDevitt DG et al (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331-1336
3. Bauer G (1993) EEG, drug effects and central nervous system poisoning. In: Niedermeyer E, Lopes da Silva S (eds) Electroencephalography. Basic principles, clinical applications, and related fields, 3rd edn. Williams & Wilkins, Baltimore, pp 631-642
4. Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S (1979) Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 136:1257-1262
5. Bocca M, Le Doze F, Etard O, Pottier M, L'Hoste J, Denise P (1999) Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacology 143:373-379
6. Bonnet MH, Arand DL (1997) Hyperarousal and insomnia. Sleep Med Rev 1:97-108
7. Brookhuis KA, Volkerts ER, O'Hanlon JF (1990) Repeated dose effects of lormetazepam and flurazepam upon driving performance. Eur J Clin Pharmacol 39:83-87
8. Coenen AML, van Luijtelaar EJM (1991) Pharmacological dissociation of EEG and behaviour: a basic problem in sleep-wake classification. Sleep 14:464-465
9. Davies M, Newell JG, Derry JMC, Martin IL, Dunn SMJ (2000) Characterization of the interaction of zopiclone with γ-aminobutyric acid type A receptor. Mol Pharmacol 58:756-762
10. de Visser SJ, van der Post JP, de Waal PP, Cornet F, Cohen AF, van Gerven JM (2003) Biomarkers for the effects of benzodiazepines in healthy volunteers. Br J Clin Pharmacol 55:39-50
11. Dupuy HJ, Engel A, Devine BK, Scanlon J, Querec L (1970) Selected symptoms of psychological distress. US Vital Health Stat 1 11:1-44
12. Freeman HL (1996) Is there a need for a para hypnotic? Approaches to the co-diagnosis of insomnia and anxiety. J Drug Dev Clin Pract 7:289-302
13. Gold MS, Miller NS, Stennie K, Populla-Vardi C (1995) Epidemiology of benzodiazepine use and dependence. Psychiatr Ann 25:146-148
14. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G (1997) Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278:27-31
15. Iudice A, Bonanni E, Maestri M, Nucciarone B, Brotini S, Manca L, Iudice G, Murri L (2002) Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers Int J Clin Pharmacol Ther 40:304-309
16. Johnson LC, Spinweber CL (1983) Good and poor sleepers differ in Navy performance. Mil Med 148:727-731
17. Karle J, Nielsen M (1998) The mechanism of action and pharmacology of zopiclone. Rev Contemp Pharmacother 9:77-87
18. Kecklund G, Akerstedt T (1993) Sleepiness in long distance truck driving: an ambulatory EEG study of night driving. Ergonomics 36(9):1007-1017
19. Lal SK, Craig A (2002) Driver fatigue: electroencephalography and psychological assessment. Psychophysiology 39(3):313-321
20. Meerlo P, Westerveld P, Turek FW, Koehl M (2004) Effects of gamma-hydroxybutyrate (GHB) on vigilance state and EEG in mice. Sleep 27:899-904
21. Mellinger GD, Balter MB, Uhlenhuth EH (1985) Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 42:225-232
22. Neutel I (1998) Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol Clin Exp 13:S115-S123
23. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF III, Kupfer DJ (1997) Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 278:2170-2177
24. Ohayon M (1996) Epidemiological study on insomnia in the general population. Sleep 19(3 Suppl):S7-S15
25. Ohayon M (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6:97-111
26. Parrott AC, Hindmarch I (1980) The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review. Psychopharmacology (Berl) 71(2):173-179
27. Regestein QR, Dambrosia J, Hallett M, Murawski B, Paine M (1993) Daytime alertness in patients with primary insomnia. Am J Psychiatry 150:1529-1534
28. Risser MR, Ware JC, Freeman FG (2000) Driving simulation with EEG monitoring in normal and obstructive sleep apnea patients. Sleep 23(3):393-398
29. Sanger DJ, Depoortere H (1998) The pharmacology and mechanism of action of zolpidem. CNS Drugs Rev 4:323-340
30. Schier MA (2000) Changes in EEG alpha power during simulated driving: a demonstration. Int J Psychophysiol 37(2):155-162
31. Schneider-Helmert D (1987) Twenty-four-hour sleep-wake function and personality patterns in chronic insomniacs and healthy controls. Sleep 10:452-462
32. Schreckenberger M, Lange-Asschenfeld C, Lochmann M, Mann K, Siessmeier T, Buchholz HG, Bartenstein P, Gründer G (2004) The thalamus as the generator and modulator of the alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans. NeuroImage 22:637-644
33. Staner L, Cornette F, Maurice D, Viardot G, Le Bon O, Haba J, Staner C, Luthringer R, Muzet A, Macher JP (2003) Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia. J Sleep Res 12:319-330
34. Stepanski E, Zorick F, Roehrs T, Young D, Roth T (1988) Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep 11:54-60
35. Torsvall L, Akerstedt T (1987) Sleepiness on the job: continuously measured EEG changes in train drivers. Electroencephalogr Clin Neurophysiol 66:502-511
36. Van Laar MW, Volkerts ER (1998) Driving and benzodiazepine use; evidence that they do not mix. CNS Drugs 10:383-396
37. Vermeeren A (2004) Residual effects of hypnotics. Epidemiology and clinical implications. CNS Drugs 18:297-328
38. Vermeeren A, O'Hanlon JF, Declerck AC (1995) Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Ther 21:47-64
39. Vermeeren A, Danjou PE, O'Hanlon JF (1998) Residual effects of evening and middle of the night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol Clin Exp 13:S98-S107
40. Vermeeren A, Riedel WJ, van Boxtel MP, Darwish M, Paty I, Patat A (2002) Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25:224-231
41. Verster JC, Volkerts ER, Verbaten MN (2002) Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study. Neuropsychopharmacology 27:260-269
42. Verster JC, Veldhuizen DS, Volkerts ER (2004) Residual effects of sleep medication on driving ability. Sleep Med Rev 8:309-325
43. Volkerts ER, O'Hanlon EF (1988) Residual effects on real car driving performance. Zopiclone versus flunitrazepam and nitrazepam. J Drug Ther Res 13:111-114
44. Volkerts ER, Louwerens JW, Gloerich ABM (1984) Zopiclone's residual effect upon actual driving performance versus those of nitrazepam and flunitrazepam. VSC, Report 84-10, Traffic Research Centre, Groningen, The Netherlands
45. Volkerts ER, Van Laar MW, Van Willigenburg AP, Plomp TA, Maas RAA (1992) A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg. Hum Psychopharmacol 7:297-309
46. Wheatley D, Balter M, Levine J, Lipman R, Bauer ML, Bonato R (1975) Psychiatric aspects of hypertension. Br J Psychiatry 127:327-336
47. Wilder A (1952) Pharmacological dissociation of behaviour and EEG sleep patterns in dogs: morphine, N-allylnormorphine and atropine. Proc Soc Exp Biol Med 79:261-265